70842-102 : Baxdela 300 mg/10.5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 70842-102
Labeler: Melinta Therapeutics, Inc
Product Type: Human Prescription Drug
Drug Name:  Baxdela
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA208611
Rev. Date: 


NDC Package Codes:

  • 70842-102-03: 1 VIAL, GLASS IN 1 CARTON (70842‑102‑03) > 10.5 ML IN 1 VIAL, GLASS

Active Ingredients:

  • Delafloxacin Meglumine

Dosage Strength:

  • 300 mg/10.5mL

Pharmaceutical Classes:

  • Fluoroquinolone Antibacterial [EPC]
  • Fluoroquinolones [CS]

Related Products:

Based on records with the same trade name.
  • 70842-101 Baxdela 450 mg Oral Tablet by Melinta Therapeutics, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70842-102 QR Code

< Prev: 70842-101Next: 70842-110 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.